CONMED Corporation (CNMD)

Currency in USD
39.90
-1.50(-3.62%)
Closed·
39.900.00(0.00%)
·
CNMD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
38.5840.96
52 wk Range
35.3764.87
Key Statistics
Prev. Close
41.4
Open
40.96
Day's Range
38.58-40.96
52 wk Range
35.37-64.87
Volume
506.44K
Average Volume (3m)
595.33K
1-Year Change
-36.4042%
Book Value / Share
33.36
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CNMD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
47.40
Upside
+18.80%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

CONMED Corporation News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

CONMED Corporation Company Profile

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, used in minimally invasive surgeries; and electrosurgical solution comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring include ECG electrodes, EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.

CONMED Corporation Earnings Call Summary for Q4/2025

  • CONMED's Q4 2025 adjusted EPS of $1.43 beat forecasts of $1.32, with revenue reaching $373.2 million (up 7.9% YoY), though stock fell 5.74% after hours.
  • The company suspended its dividend and approved a $150 million share repurchase program while reporting full-year 2025 sales of $1.375 billion (up 5.2% from 2024).
  • CONMED faces challenges with a high leverage ratio of 2.9x and $834.2 million in long-term debt against a $40.8 million cash balance.
  • For 2026, the company projects revenue between $1.345-1.375 billion (4.5-6% organic growth), adjusted EPS of $4.30-4.45, and adjusted EBITDA of $255-265 million.
  • CEO Pat Beyer emphasized the company's focus on innovation and minimally invasive surgery, highlighting the $1 billion global surgical smoke evacuation market opportunity.
Last Updated: 02/03/2026, 05:54 PM
Read Full Transcript

Compare CNMD to Peers and Sector

Metrics to compare
CNMD
Peers
Sector
Relationship
P/E Ratio
26.1x25.4x−0.5x
PEG Ratio
−0.420.360.00
Price/Book
1.2x3.2x2.6x
Price / LTM Sales
0.9x3.1x3.2x
Upside (Analyst Target)
8.7%78.4%51.4%
Fair Value Upside
Unlock38.9%8.5%Unlock

Analyst Ratings

1 Buy
5 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 47.40
(+18.80% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Wells Fargo
Hold42.00+5.26%41.00MaintainJan 29, 2026
Wells Fargo
Hold47.00+17.79%57.00MaintainNov 06, 2025
Piper Sandler
Buy55.00+37.84%68.00MaintainNov 06, 2025
JPMorgan
Hold52.00+30.33%58.00MaintainNov 06, 2025
Needham
Hold---MaintainNov 06, 2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.51%
Dividend Yield
2.01%
Industry Median 1.48%
Annualized payout
0.80
Paid quarterly
5-Years Growth
-5.59%
Growth Streak

Earnings

Latest Release
Jan 28, 2026
EPS / Forecast
1.43 / 1.32
Revenue / Forecast
373.20M / 366.97M
EPS Revisions
Last 90 days

CNMD Income Statement

People Also Watch

64.13
HAE
-0.16%
19.75
MD
+2.38%
144.47
MOH
-2.19%
145.92
EPAM
+0.93%

FAQ

What Is the CONMED (CNMD) Stock Price Today?

The CONMED stock price today is 39.90 USD.

What Stock Exchange Does CONMED Trade On?

CONMED is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for CONMED?

The stock symbol for CONMED is "CNMD."

Does CONMED Pay Dividends? What’s The Current Dividend Yield?

The CONMED dividend yield is 2.01%.

What Is the CONMED Market Cap?

As of today, CONMED market cap is 1.24B USD.

What Is CONMED's Earnings Per Share (TTM)?

The CONMED EPS (TTM) is 1.51.

When Is the Next CONMED Earnings Date?

CONMED will release its next earnings report on May 06, 2026.

From a Technical Analysis Perspective, Is CNMD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has CONMED Stock Split?

CONMED has split 3 times.

How Many Employees Does CONMED Have?

CONMED has 3900 employees.

What is the current trading status of CONMED (CNMD)?

As of Mar 07, 2026, CONMED (CNMD) is trading at a price of 39.90 USD, with a previous close of 41.40 USD. The stock has fluctuated within a day range of 38.58 USD to 40.96 USD, while its 52-week range spans from 35.37 USD to 64.87 USD.

What Is CONMED (CNMD) Price Target According to Analysts?

The average 12-month price target for CONMED is 47.40 USD, with a high estimate of 55 USD and a low estimate of 42 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +18.80% Upside potential.

What Is the CNMD Premarket Price?

CNMD's last pre-market stock price is 41.30 USD. The pre-market share volume is 14,170.00, and the stock has decreased by -0.10, or -0.24%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.